Molecular analysis of rifampicin-resistant Mycobacterium tuberculosis isolated in Spain (1996-2001).: Description of new mutations in the rpoB gene and review of the literature

被引:62
作者
Herrera, L [1 ]
Jiménez, S [1 ]
Valverde, A [1 ]
García-Aranda, MA [1 ]
Sáez-Nieto, JA [1 ]
机构
[1] Inst Salud Carlos III, Ctr Nacl Microbiol, Serv Bacteriol, Mycobacterial Reference Lab, Madrid 28220, Spain
关键词
rpoB gene; M; tuberculosis; rifampicin-resistance; Spain;
D O I
10.1016/S0924-8579(03)00036-0
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Mutations of the 81-bp-core region of rpoB gene associated with rifampicin resistance were studied in 169 clinical strains of Mycobacterium tuberculosis isolated from Spain between 1996 and 2001. The analysis identified 16 single base changes, one deletion, two insertions and five multiple mutations (with two or three codons implicated). Eight strains had no mutations, although they were resistant by the proportion method. The five single nucleotide changes with two or three codons implicated and one insertion have not been previously reported. The analysis of the RFLP-IS6110 pattern showed a great heterogeneity (159 individual patterns and four patterns with two or three strains) that suggests no geographical or temporal relations between the studied strains. The concordance rate of InnoLipa Rif-Tb probe with sequencing and phenotypic methods was 94.6%. The results indicate that the InnoLipa probe assay may be useful for rapid screening of the most frequent mutations found in rifampicin-resistant M. tuberculosis strains. (C) 2003 Elsevier Science B.V. and the International Society of Chemotherapy. All rights reserved.
引用
收藏
页码:403 / 408
页数:6
相关论文
共 31 条
[1]   Characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from the Middle East [J].
Ahmad, S ;
Araj, GF ;
Akbar, PK ;
Fares, E ;
Chugh, TD ;
Mustafa, AS .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 2000, 38 (04) :227-232
[2]   Molecular characterization of rifampin-resistant isolates of Mycobacterium tuberculosis from Hungary by DNA sequencing and the line probe assay [J].
Bártfai, Z ;
Somoskövi, A ;
Ködmön, C ;
Szabó, N ;
Puskás, E ;
Kosztolányi, L ;
Faragó, E ;
Mester, J ;
Parsons, LM ;
Salfinger, M .
JOURNAL OF CLINICAL MICROBIOLOGY, 2001, 39 (10) :3736-3739
[3]  
CANETTI G, 1969, B WORLD HEALTH ORGAN, V41, P21
[4]   Detection of rifampin resistance among isolates of Mycobacterium tuberculosis from Mozambique [J].
Caugant, DA ;
Sandven, P ;
Eng, J ;
Jeque, JT ;
Tonjum, T .
MICROBIAL DRUG RESISTANCE-MECHANISMS EPIDEMIOLOGY AND DISEASE, 1995, 1 (04) :321-326
[5]  
Chaves F, 2000, INT J TUBERC LUNG D, V4, P765
[6]   Drug-resistant tuberculosis: Review of the worldwide situation and the WHO/IUATLD global surveillance project [J].
Cohn, DL ;
Bustreo, F ;
Raviglione, MC .
CLINICAL INFECTIOUS DISEASES, 1997, 24 :S121-S130
[7]   Evaluation of a line probe assay kit for characterization of rpoB mutations in rifampin-resistant Mycobacterium tuberculosis isolates from new York City [J].
Cooksey, RC ;
Morlock, GP ;
Glickman, S ;
Crawford, JT .
JOURNAL OF CLINICAL MICROBIOLOGY, 1997, 35 (05) :1281-1283
[8]   RIBOSYLATION BY MYCOBACTERIAL STRAINS AS A NEW MECHANISM OF RIFAMPIN INACTIVATION [J].
DABBS, ER ;
YAZAWA, K ;
MIKAMI, Y ;
MIYAJI, M ;
MORISAKI, N ;
IWASAKI, S ;
FURIHATA, K .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1995, 39 (04) :1007-1009
[9]   Molecular evidence for heterogeneity of the multiple-drug-resistant Mycobacterium tuberculosis population in Scotland (1990 to 1997) [J].
Fang, Z ;
Doig, C ;
Rayner, A ;
Kenna, DT ;
Watt, B ;
Forbes, KJ .
JOURNAL OF CLINICAL MICROBIOLOGY, 1999, 37 (04) :998-1003
[10]  
Gonzalez N, 1998, Enferm Infecc Microbiol Clin, V16, P404